Table1.
Group A(n = 52) | Group B(n = 51) | |
---|---|---|
age(Y) | 26.25 ± 3.34 | 26.49 ± 2.80 |
weight(Kg) | 67.95 ± 7.89 | 69.29 ± 9.18 |
height(m) | 1.60 ± 0.04 | 1.61 ± 0.05 |
BMI(Kg/m2) | 26.62 ± 2.90 | 26.71 ± 2.88 |
Gestation(weeks) | 39.08 ± 0.99 | 38.98 ± 0.93 |
Labour (n (%)) | ||
Spontaneous | 45(86.5%) | 44(86.28%) |
instrumental | 0(0) | 1(1.96%) |
cesarean delivery | 7(13.5%) | 6(11.8%) |
Oxytocin administration, n (%) | 16(30.8%) | 15(29.4%) |
Cervical dilation at onset of study(cm), median (IQR) | 2(2,3) | 2(2,3) |
hourly consumption of ropivacaine(mg) | 11.25 | 13.5 |
Adverse event (n (%)) | ||
pruritus | 2(3.85%) | 1(1.96%) |
hypotension | 0(0) | 0(0) |
urinary retention | 0(0) | 0(0) |
Values are presented as mean (SD), number (%), or median (IQR), BMI Body mass index, IQR Interquartile range, SD Standard deviation, Y Years old, Kg Kilogram, m Meters